5-Hydroxytryptamine-3 Antagonists: A New Class of Potent Antiemetics in Cancer Therapy

This publication has 9 references indexed in Scilit:

• Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy
  British Journal of Cancer, 1990
• Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species
  European Journal of Pharmacology, 1989
• Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist
  British Journal of Cancer, 1988
• Antiemetic properties of the 5HT3-receptor antagonist, gr38032f
  Cancer Treatment Reviews, 1987
• Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding
  Nature, 1987
• Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism
  British Journal of Pharmacology, 1986
• Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
  New England Journal of Medicine, 1981
• Blockade of serotonin receptors on autonomic neurones by (−)-cocaine and some related compounds
  European Journal of Pharmacology, 1979
• SERUM VASOCONSTRICTOR (SEROTONIN)
  Journal of Biological Chemistry, 1948